Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs
The Pharma Data
JANUARY 17, 2021
. “Rolontis,” a treatment for neutropenia that had its technology licensed out to Spectrum Pharmaceuticals, Inc. and “Oraxol,” which was licensed out to Athenex, Inc. “R&D capabilities of Hanmi Pharmaceutical Co., Hanmi Pharmaceutical Co.,
Let's personalize your content